Patent · US Active

Immunogenic CD1d binding peptides

US11485768B2 · kind B2 · utility

2Cited by

22References

19Claims

0Family size

Assignee

IMCYSE SA · BE

Inventor

Luc Vander Elst · Obaix, BE

Key dates

Filing date	Apr 19, 2017
Grant date	Nov 1, 2022
Priority date	—
Expiry date	Nov 18, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2239/38
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to isolated immunogenic peptides comprising a CD1d binding peptide, and immediately adjacent or separated from said CD1d binding peptide, a redox motif sequence which is further flanked by a histidine or tryptophan amino acids. The invention further relates to these peptides for use as a medicament The invention further relates to methods wherein these peptides are used for generating NKT cells which are cytolytic against cells presenting the cognate antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.